Oxidant-mediated repression of mitochondrial transcription in diabetic rats

Free Radical Biology and Medicine

Volumn 22, Issue 5, 1997, Pages 813-822

  Kristal, Bruce S ^a,c   Koopmans, Sietse J ^b,d   Jackson, Chris T ^a   Ikeno, Yuji ^a   Park, Bum Jun ^a,e   Yu, Byung P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Chon Nam Univ School of Medicine   (South Korea)

Author keywords

Diabetes; Free radicals; Ketones; Mitochondria; Transcription

Indexed keywords

FREE RADICAL; KETONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TRANSCRIPTION REGULATION;

AMIDINES; ANIMALS; AZO COMPOUNDS; DIABETES MELLITUS, EXPERIMENTAL; FREE RADICALS; LIPID PEROXIDATION; MITOCHONDRIA, LIVER; NITRILES; OXIDANTS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION, GENETIC;

EID: 0031020263     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00429-7     Document Type: Article

References (34)

1. Hall J. C., Sordahl L. A., Stefko P. L. The effect of insulin on oxidative phosphorylation in normal and diabetic mitochondria. J. Biol. Chem. 235:1960;1536-1539.
2. Mokhtar N., Lavoie J. P., Rousseau-Migneron S., Nadeau A. Physical training reverses defect in mitochondrial energy production in heart of chronically diabetic rats. Diabetes. 42:1993;682-687.
3. Tanaka Y., Konno N., Kako K. J. Mitochondrial dysfunction observed in situ in cardiomyocytes of rats in experimental diabetes. Cardiovasc. Res. 26:1992;409-414.
4. Brignone J. A., de Brignone C. M. C., de Mignone I. R., Ricci C. R., Susemihl M. C., Rodriguez R. R. Improving effects obtained by the ovariectomy or treatment with tamoxifen of female diabetic rats over the function and enzyme activities of liver mitochondria. Horm. Metab. Res. 23:1991;51-61.
5. Bedetti C. D., Montero G. A., Stoppani A. O. M. Effect of diabetes, adrenalectomy, and hypophysectomy on D-3-hydroxybutyrate dehydrogenase activity and substrate oxidation by rat mitochondria. Biochem. Int. 14:1987;45-54.
6. Churchill P., McIntyre J. O., Vidal J. C., Fleischer S. Basis for decreased D- βhydroxybutyrate dehydrogenase activity in liver mitochondria from diabetic rats. Arch. Biochem. Biophys. 224:1983;659-670.
7. Grinblat L., Bedetti C. D., Stoppani A. O. M. Calcium transport and energy coupling in diabetic rat liver mitochondria. Biochem. Int. 17:1988;329-335.
8. Rinehart R. W., Roberson J., Beattie D. S. The effect of diabetes on protein synthesis and the respiratory chain of rat skeletal muscle and kidney mitochondria. Arch. Biochem. Biophys. 213:1982;341-352.
9. Bandy B., Davison A. J. Mitochondrial mutations may increase oxidative stress: Implications for carcinogenesis and aging? Free Radic. Biol. Med. 8:1990;523-539.
10. Shoffner J. M., Wallace D. C. Oxidative phosphorylation diseases and mitochondrial DNA mutations: Diagnosis and treatment. Annu. Rev. Biochem. 63:1994;535-568.
11. Wallace D. C. Mitochondrial genetics: A paradigm for aging and degenerative diseases. Science. 256:1992;628-632.
12. Sukalski K. A., Pinto K. A., Berntson J. L. Decreased susceptibility of liver mitochondria from diabetic rats to oxidative damage and associated increase and α -tocopherol. Free Radic. Biol. Med. 14:1993;57-65.
13. Kristal B. S., Chen J. J., Yu B. P. Sensitivity of mitochondrial transcription to different free radical species. Free Radic. Biol. Med. 16:1994;323-329.
14. Kristal B. S., Park B. J., Yu B. P. Antioxidants reduce peroxyl-mediated inhibition of mitochondrial transcription. Free Radic. Biol. Med. 16:1994;653-660.
15. Kristal B. S., Kim J. D., Yu B. P. Tissue-specific defenses against free radical-mediated inhibition of mitochondrial transcription. Redox Report. 1:1994;51-55.
16. Aebi H. Catalase in vitro. Methods Enzymol. 105:1984;121-126.
17. Cohen G., Dembiec D., Marcus J. Measurement of catalase activity in tissue extracts. Anal. Biochem. 34:1970;30-38.
18. Flohe L., Gunzler W. A. Assays of glutathione peroxidase. Methods Enzymol. 105:1984;114-121.
19. McCord J. M., Fridovich I. Superoxide dismutase. J. Biol. Chem. 244:1969;6049-6055.
20. Flohe L., Otting F. Superoxide dismutase assays. Methods Enzymol. 105:1984;93-104.
21. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun. 6:1989;67-75.
22. Esterbauer H., Schaur R. J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde, and related aldehydes. Free Radic. Biol. Med. 11:1991;81-128.
23. Kristal B. S., Park B. K., Yu B. P. 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J. Biol. Chem. 271:1996;6033-6038.
24. Chen J.J., Bertrand H., Yu B.P. Inhibition of adenine nucleotide translocator by lipid peroxidation products. Free Radic. Biol. Med. 19:1995;583-590.
25. Sato K., Niki E., Shimasaki H. Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and C. Arch Biochem. Biophys. 279:1990;403-405.
26. Niki E., Yamamoto Y., Komuro E., Sato K. Membrane damage due to lipid oxidation. Am. J. Clin. Nutr. 53:1991;201S-205S.
27. Wagner B. A., Buettner G. R., Burns C. P. Free radical-mediated lipid peroxidation in cells: Oxidizability is a function of cell lipid bis-allylic hydrogen bonds. Biochemistry. 33:1994;4449-4453.
28. Takenaka Y., Miki M., Yasuda H. The effect of α -tocopherol as an antioxidant on the oxidation of membrane protein thiols induced by free radicals generated at different sites. Arch. Biochem. Biophys. 285:1991;344-350.
29. Kristal B. S., Jackson C. T., Chung H.-Y., Matsuda M., Nguyen H. D., Yu B. P. Defects at Center P underlie diabetes-associated mitochondrial dysfunction. Free Radic. Biol. Med. 22:1997;823-833.
30. Shoffner J. M., Wallace D. C. Oxidative phosphorylation diseases and mitochondrial DNA mutations: Diagnosis and treatment. Annu. Rev. Nutr. 14:1994;535-568.
31. Shoffner J. M., Lott M. T., Lezza A. M. S., Seibel P., Ballinger S. W., Wallace D. C. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell. 61:1990;931-937.
32. Chomyn A., Martinuzzi A., Yoneda M., Daga A., Hurko O., Johns D., Lai S. T., Nonaka I., Angelini C., Attardi G. MELAS mutation in mtDNA binding site for transcriptional termination factor causes defects in protein synthesis and in respiration but no changes in mature upstream and downstream transcripts. Proc. Natl. Acad. Sci. USA. 89:1992;4221-4225.
33. Wallace D. C., Lott M. T., Shoffner J. M., Ballinger S. Mitochondrial DNA mutations in epilepsy and neurological disease. Epilepsia. 35:(Suppl 1):1994;S43-S50.
34. Harano Y., DePalma R. G., Lavine L., Miller M. Fatty acid oxidation, oxidative phosphorylation and ultrastructure of mitochondria in the diabetic liver. Diabetes. 21:1972;257-270.